I truely couldn't agree with you more. As this is a small co. it will follow the general trends of the macro.
IMO Biotech has been beaten up since last year, this is gonna re-rate SO hard once mid-year comes by. Just have to be patient, as always. Great news is, that this drug is safe and has favourable outcomes, to be further tested in larger sample sizes for confirmation. Exciting times ahead, and with this BOD calibre, I am very confident in my LT portfolio. Just gotta keep accumulating
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |